Weight loss drugs are incredibly sought-after, but they’re also often difficult to obtain due to limited insurance coverage ...

Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

The type 2 diabetes medication Ozempic has been hugely popular when prescribed off-label for weight loss, thanks to its ...

Lucrative weight loss drugs are new focus for diabetes patients The insulin supply shortages come as diabetes patients increasingly turn to drugs such as Ozempic and Mounjaro, part of a new ...

While Ozempic has been shown to lead to weight loss as a side effect, it's not without risks. According to the Cleveland ...

Even if you you’re not diabetic or obese, can Ozempic be right for you? Ever since the weekly injectable was approved in 2017 ...

Novo Nordisk, the pharma giant behind Ozempic and Wegovy, has surprising love story origins. The founders, a married couple, ...

The UK’s drug’s watchdog has warned people over the use of counterfeit medications which could contain insulin - with many ...

MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...

Researchers at Case Western Reserve school of Medicine looked at nearly one million patients in the U.S. with Type 2 diabetes ...

Semaglutide, the active ingredient in Ozempic, has shown promising results in weight loss ... “Additionally, many women ...

Lucrative weight loss drugs are new focus for diabetes patients The insulin supply shortages come as diabetes patients ...